9.1(top 1%)
Impact Factor
10.2(top 1%)
extended IF
52(top 8%)
H-Index
246
authors
333
papers
9.4K
citations
1.1K
citing journals
5.1K
citing authors

Most Cited Articles of Liver Cancer

TitleYearCitations
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan2014394
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)2018291
Treatment of hepatocellular carcinoma: a systematic review2012218
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan2015149
Emerging signaling pathways in hepatocellular carcinoma2012144
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma2015130
Molecular biology of liver cancer stem cells2014128
From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence2013124
Epidemiology and surveillance of hepatocellular carcinoma2012124
Hepatic iron overload and hepatocellular carcinoma2014117
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)2020108
Surgical and Locoregional Therapy of HCC: TACE2015105
Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function2017102
Liver resection and transplantation in hepatocellular carcinoma2012102
Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC201598
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications201796
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan201692
How to define transarterial chemoembolization failure or refractoriness: a European perspective201490
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis201988
Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy201288
Recent Advances in Tumor Ablation for Hepatocellular Carcinoma201582
Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment201681
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges201680
Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china201379
The 10th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2019), Sapporo, Japan, August 29-31, 2019201978